Dr. Reddy’s Laboratories Ltd. announced the launch of Cresp- the first generic darbepoetin alfa in the world, and the only darbepoetin alfa in India. Cresp has been approved in India for the treatment of anemia due to chronic kidney disease and anemia due to chemotherapy.Darbepoetin alfa is a modified version of epoetin alfa (rHuEPO), which is engineered to have a longer half life, increasing (up to 3 times) the time it remains in the blood. This results in a reduced frequency of doses, providing a simpler and more convenient treatment option for patients and physicians as compared to treatment of anemia with epoetin which is the current standard of care in India.Dr. Reddy’s will be launching Cresp in both vials and prefilled syringes (PFS).
Like
Dislike
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.
"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!
